Enhanced Airway Inflammation and Remodeling in Adenosine Deaminase-Deficient Mice Lacking the A2B Adenosine Receptor

被引:47
作者
Zhou, Yang [1 ]
Mohsenin, Amir [1 ]
Morschl, Eva [1 ]
Young, Hays W. J. [1 ]
Molina, Jose G. [1 ]
Ma, Wenbin [2 ]
Sun, Chun-Xiao [1 ]
Martinez-Valdez, Hector [2 ]
Blackburn, Michael R. [1 ]
机构
[1] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
OBSTRUCTIVE PULMONARY-DISEASE; HUMAN MAST-CELLS; PROINFLAMMATORY CYTOKINES; NEUTROPHIL ELASTASE; MUCIN PRODUCTION; MURINE COLITIS; GENE ABLATION; LUNG INJURY; FIBROSIS; ASTHMA;
D O I
10.4049/jimmunol.0900515
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Adenosine is a signaling nucleoside that is generated in response to cellular injury and orchestrates the balance between tissue protection and the progression to pathological tissue remodeling. Adenosine deaminase (ADA)-deficient mice develop progressive airway inflammation and remodeling in association with adenosine elevations, suggesting that adenosine can promote features of chronic lung disease. Furthermore, pharmacological studies in ADA-deficient mice demonstrate that A(2B)R antagonism can attenuate features of chronic lung disease, implicating this receptor in the progression of chronic lung disease. This study examines the contribution of A(2B)R signaling in this model by generating ADA/A(2B)R double-knockout mice. Our hypothesis was that genetic removal of the A(2B)R from ADA-deficient mice would lead to diminished pulmonary inflammation and damage. Unexpectedly, ADA/A(2B)R double-knockout mice exhibited enhanced pulmonary inflammation and airway destruction. Marked loss of pulmonary barrier function and excessive airway neutrophilia are thought to contribute to the enhanced tissue damage observed. These findings support an important protective role for A(2B)R signaling during acute stages of lung disease. The Journal of Immunology, 2009, 182: 8037-8046.
引用
收藏
页码:8037 / 8046
页数:10
相关论文
共 50 条
  • [21] The discovery of a selective, high affinity A2B adenosine receptor antagonist for the potential treatment of asthma
    Zablocki, J
    Kalla, R
    Perry, T
    Palle, V
    Varkhedkar, V
    Xiao, DM
    Piscopio, A
    Maa, T
    Gimbel, A
    Hao, J
    Chu, N
    Leung, K
    Zeng, DW
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (03) : 609 - 612
  • [22] Enhanced IL-6 transcriptional response to adenosine receptor ligands in horses with lower airway inflammation
    Zhang, L.
    Franchini, M.
    Eser, M. Wehrli
    Dip, R.
    EQUINE VETERINARY JOURNAL, 2012, 44 (01) : 81 - 87
  • [23] Inhibition of Adenosine A2B Receptor Ameliorates Renal Fibrosis by Regulating Macrophage Infiltration and Polarization
    Xie, Tingting
    Li, Guoli
    Yang, Hui
    Wang, Xuan
    Li, Jiarong
    Zhang, Weiru
    CIRCULATION, 2017, 136
  • [24] Progress in the discovery of selective, high affinity A2B adenosine receptor antagonists as clinical candidates
    Rao V. Kalla
    Jeff Zablocki
    Purinergic Signalling, 2009, 5 : 21 - 29
  • [25] A2B adenosine receptor antagonists: Design, synthesis and biological evaluation of novel xanthine derivatives
    Basu, Sujay
    Barawkar, Dinesh A.
    Ramdas, Vidya
    Waman, Yogesh
    Patel, Meena
    Panmand, Anil
    Kumar, Santosh
    Thorat, Sachin
    Bonagiri, Rajesh
    Jadhav, Dilip
    Mukhopadhyay, Partha
    Prasad, Vandna
    Reddy, B. Srinivasa
    Goswami, Arnab
    Chaturvedi, Sandhya
    Menon, Suraj
    Quraishi, Azfar
    Ghosh, Indraneel
    Dusange, Sushant
    Paliwal, Shalini
    Kulkarni, Abhay
    Karande, Vikas
    Thakre, Rhishikesh
    Bedse, Gaurav
    Rouduri, Sreekanth
    Gundu, Jayasagar
    Palle, Venkata P.
    Chugh, Anita
    Mookhtiar, Kasim A.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 127 : 986 - 996
  • [26] Discovery of benzothiazole-based adenosine A2B receptor antagonists with improved A2A selectivity
    Firooznia, Fariborz
    Cheung, Adrian Wai-Hing
    Brinkman, John
    Grimsby, Joseph
    Gubler, Mary Lou
    Hamid, Rachid
    Marcopulos, Nicholas
    Ramsey, Gwendolyn
    Tan, Jenny
    Wen, Yang
    Sarabu, Ramakanth
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (07) : 1933 - 1936
  • [27] New pyrrolopyrimidin-6-yl benzenesulfonamides:: Potent A2B adenosine receptor antagonists
    Esteve, Cristina
    Nueda, Arsenio
    Diaz, Jose Luis
    Beleta, Jorge
    Cardenas, Alvaro
    Lozoya, Estrella
    Cadavid, Maria Isabel
    Loza, Maria Isabel
    Ryder, Hamish
    Vidal, Bernat
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (14) : 3642 - 3645
  • [28] Progress in the discovery of selective, high affinity A2B adenosine receptor antagonists as clinical candidates
    Kalla, Rao V.
    Zablocki, Jeff
    PURINERGIC SIGNALLING, 2009, 5 (01) : 21 - 29
  • [29] The adenosine A2B G protein-coupled receptor: Recent advances and therapeutic implications
    Vecchio, Elizabeth A.
    White, Paul J.
    May, Lauren T.
    PHARMACOLOGY & THERAPEUTICS, 2019, 198 : 20 - 33
  • [30] 1-Alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: Development and Characterization of Adenosine A2B Receptor Antagonists and a New Radioligand with Subnanomolar Affinity and Subtype Specificity
    Borrmann, Thomas
    Hinz, Sonja
    Lertarelli, Daniela C. G.
    Li, Wenjin
    Florin, Nicole C.
    Scheiff, Anja B.
    Mueller, Christa E.
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (13) : 3994 - 4006